Clinical trial
Pharmacogenomics Blood Sampling Protocol For…
NCT00140036 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00140036 |
|---|---|
| Title | Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV). |
| Official title | Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV). |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Procedure |
| Interventions | Blood draw |
| Enrollment | 137 |
| Start date | Sep 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Aug 31, 2005 |
| Last update posted | Mar 3, 2008 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: